Given the immunogenic nature of MOC1 and consistent with previous literature (34), there were substantially more CD4+ and CD8+ T lymphocytes present in MOC1 tumor tissue when qualitatively compared to MOC2 tumor tissue. The gene discussed is CD4; the disease is neoplasm.